Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas.
The behavior of the activity of 5-phosphoribosyl 1-pyrophosphate (PRPP) synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) was elucidated in normal rat liver, in 11 hepatomas of different growth rates, and in rapidly growing differentiating and regenerating liver. Tissue extracts were prepared by centrifugation of 10% homogenates at 100,000 X g for 30 min, and enzyme activity was measured in the protein fractions obtained by 40 and 47% ammonium sulfate saturation of the supernatant fluids from livers and hepatomas, respectively. In the tissue extracts, there was no interfering enzyme activity that utilized PRPP under the standard assay conditions. The affinity of PRPP synthetase for its substrates, ribose 5-phosphate and adenosine triphosphate (ATP), and to Mg2+ was similar in liver and hepatoma extracts. The Km for ribose 5-phosphate was 0.3 mM; for ATP, it was 0.1 mM in the presence of excess Mg2+. The Km for Mg2+ ATP was 1.2 mM in the presence of excess ATP. There was no difference in the affinity of the enzyme for its activators, Mg2+ and inorganic phosphate, in liver and hepatoma preparations; the Km for Mg2+ was 0.6 mM in the presence of excess ATP; the Km for inorganic phosphate was 14.0 mM. The requirement of hepatoma extracts for full phosphate saturation was higher than that of liver extracts (85 versus 65 mM). A standard assay was worked out for the liver and hepatoma systems; in liver, the enzyme activity was linear for 30 min incubation, and in hepatoma it was linear for 15 min incubation. PRPP synthetase activity was proportionate with amounts of protein added over a range of 0.4 to 3.0 mg in both liver and hepatoma extracts. In the liver of normal adult Wistar rats, PRPP synthetase activity was 108 +/- 10 nmol/hr/mg protein. In rat tissues of high cell renewal activity, thymus, testis, spleen, and small intestine, synthetase specific activity was 3.7-, 3.6-, 1.2-, and 1.3-fold higher than that of normal liver. The synthetase specific activity in hepatomas of slow growth rate increased 1.2- to 1.5-fold, and in intermediate and rapidly growing hepatomas it was elevated 1.9- to 4.1-fold higher than that of normal liver.(ABSTRACT TRUNCATED AT 400 WORDS)
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D008114:Liver Neoplasms, Experimental / Q000201:enzymology*; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D010710:Phosphates / Q000494:pharmacology; D010770:Phosphotransferases / Q000378:metabolism*; D051381:Rats; D011912:Rats, Inbred ACI; D011915:Rats, Inbred BUF; D012268:Ribose-Phosphate Pyrophosphokinase / Q000302:isolation & purification / Q000378:metabolism*; D014018:Tissue Distribution
D010710:Phosphates; D000255:Adenosine Triphosphate; D010770:Phosphotransferases; D012268:Ribose-Phosphate Pyrophosphokinase; D008274:Magnesium